SUMER JACQUELYN L 4
4 · Cullinan Oncology, Inc. · Filed Feb 21, 2023
Insider Transaction Report
Form 4
SUMER JACQUELYN L
Chief Legal Officer
Transactions
- Award
Common Stock
2023-02-17+47,000→ 47,000 total - Award
Stock Option (Right to Buy)
2023-02-17+93,500→ 93,500 totalExercise: $11.34Exp: 2033-02-16→ Common Stock (93,500 underlying)
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.